$LIVN
LivaNova PLC Stock $livn

$livn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000163969124000109 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$318.1M	$318.6M
YoY Change	11.19%	8.4%
Cost Of Revenue	$92.86M	$99.71M
YoY Change	10.14%	12.43%
Gross Profit	$225.3M	$218.9M
YoY Change	11.63%	6.66%
Gross Profit Margin	70.81%	68.7%
Selling, General & Admin	$131.7M	$129.1M
YoY Change	-2.32%	2.58%
% of Gross Profit	58.45%	58.99%
Research & Development	$48.81M	$44.74M
YoY Change	4.86%	-12.49%
% of Gross Profit	21.67%	20.44%
Depreciation & Amortization	$10.64M	$10.41M
YoY Change	-18.12%	-16.6%
% of Gross Profit	4.73%	4.75%
Operating Expenses	$180.5M	$173.9M
YoY Change	-0.48%	-7.44%
Operating Profit	$35.62M	$40.17M
YoY Change	698.97%	131.16%
Interest Expense	$8.800M	-$18.50M
YoY Change	-41.28%	-3734.58%
% of Operating Profit	24.71%	-46.06%
Other Income/Expense, Net	$275.0K	$104.0K
YoY Change	59.88%	-100.83%
Pretax Income	$44.44M	$21.59M
YoY Change	-2346.76%	308.88%
Income Tax	$11.53M	$5.227M
% Of Pretax Income	25.93%	24.21%
Net Earnings	$32.95M	$16.33M
YoY Change	-550.3%	1314.11%
Net Earnings / Revenue	10.36%	5.13%
Basic Earnings Per Share	$0.61	$0.30
Diluted Earnings Per Share	$0.60	$0.30
COMMON SHARES
Basic Shares Outstanding	54.30M shares	54.15M shares
Diluted Shares Outstanding	54.59M shares	54.59M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$346.4M	$329.2M
YoY Change	48.1%	47.67%
Cash & Equivalents	$346.4M	$329.2M
Short-Term Investments
Other Short-Term Assets	$387.2M	$361.9M
YoY Change	5.07%	-3.9%
Inventory	$162.3M	$154.7M
Prepaid Expenses
Receivables	$197.2M	$200.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.093B	$1.047B
YoY Change	14.6%	11.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$169.3M	$158.1M
YoY Change	13.41%	-13.98%
Goodwill	$781.6M	$766.4M
YoY Change	1.89%	-1.65%
Intangibles	$248.5M	$248.2M
YoY Change	-28.51%	-30.56%
Long-Term Investments	$18.10M	$17.20M
YoY Change	-20.26%	-20.83%
Other Assets	$14.37M	$14.36M
YoY Change	18.65%	-75.08%
Total Long-Term Assets	$1.429B	$1.406B
YoY Change	3.87%	0.48%
TOTAL ASSETS
Total Short-Term Assets	$1.093B	$1.047B
Total Long-Term Assets	$1.429B	$1.406B
Total Assets	$2.522B	$2.453B
YoY Change	8.27%	4.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.89M	$81.32M
YoY Change	24.07%	3.98%
Accrued Expenses	$104.5M	$97.97M
YoY Change	16.55%	-22.89%
Deferred Revenue	$10.28M	$10.23M
YoY Change	-6.29%	-7.4%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$21.25M	$19.11M
YoY Change	15.4%	0.16%
Total Short-Term Liabilities	$324.4M	$303.0M
YoY Change	9.82%	5.14%
LONG-TERM LIABILITIES
Long-Term Debt	$604.3M	$605.4M
YoY Change	6.36%	6.6%
Other Long-Term Liabilities	$47.04M	$44.90M
YoY Change	1.69%	-80.97%
Total Long-Term Liabilities	$651.3M	$650.3M
YoY Change	6.01%	-19.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$324.4M	$303.0M
Total Long-Term Liabilities	$651.3M	$650.3M
Total Liabilities	$1.212B	$1.211B
YoY Change	9.78%	9.96%
SHAREHOLDERS EQUITY
Retained Earnings	-$959.1M	-$992.1M
YoY Change	-2.41%	1.7%
Common Stock	$2.296B	$2.288B
YoY Change	1.45%	1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$195.0K
YoY Change		105.26%
Treasury Stock Shares
Shareholders Equity	$1.310B	$1.243B
YoY Change
Total Liabilities & Shareholders Equity	$2.522B	$2.453B
YoY Change	8.27%	4.77%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$32.95M	$16.33M
YoY Change	-550.3%	1314.11%
Depreciation, Depletion And Amortization	$10.64M	$10.41M
YoY Change	-18.12%	-16.6%
Cash From Operating Activities	$51.06M	$43.22M
YoY Change	180.57%	-340.95%
INVESTING ACTIVITIES
Capital Expenditures	$18.15M	$12.20M
YoY Change	106.2%	115.62%
Acquisitions
YoY Change
Other Investing Activities	-$422.0K	-$335.0K
YoY Change	-67.54%	-66.37%
Cash From Investing Activities	-$18.57M	-$12.54M
YoY Change	83.84%	88.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.277M	-11.85M
YoY Change	-23.79%	-132.9%
NET CHANGE
Cash From Operating Activities	51.06M	43.22M
Cash From Investing Activities	-18.57M	-12.54M
Cash From Financing Activities	-3.277M	-11.85M
Net Change In Cash	29.22M	18.84M
YoY Change	668.89%	64.9%
FREE CASH FLOW
Cash From Operating Activities	$51.06M	$43.22M
Capital Expenditures	$18.15M	$12.20M
Free Cash Flow	$32.92M	$31.02M
YoY Change	250.18%	-231.45%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	55000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	16290000	usd
	us-gaap	Depreciation Depreciation	12040000	usd
	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	25332000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	195000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25482000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18425000	usd
	livn	Remeasurement Of Capped Call And Embedded Exchange Feature RemeasurementOfCappedCallAndEmbeddedExchangeFeature	-12465000	usd
	us-gaap	Depreciation Depreciation	12441000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10195000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	9535000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	8615000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	12747000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	5750000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5556000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	85000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4377000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5107000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3682000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5698000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	911000	usd
	us-gaap	Restructuring Charges RestructuringCharges	11364000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	8407000	usd
CY2024Q2	us-gaap	Restructuring Reserve RestructuringReserve	3868000	usd
CY2024Q2	us-gaap	Restructuring Charges RestructuringCharges	2139000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	624537000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	586027000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	19105000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	17484000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	605432000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	568543000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25500000	usd
CY2016	livn	Reimbursed Legal Fees ReimbursedLegalFees	292000	eur
	livn	Reimbursed Legal Fees ReimbursedLegalFees	312440000	usd
CY2024Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	15968000	usd
CY2024Q2	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	3009000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1221537000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12285000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	16333000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7613000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1242542000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1227341000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6659000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5453000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1240608000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1277628000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15460000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25610000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-24936000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1242542000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1207624000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11919000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8525000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12540000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1240608000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-24936000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-24936000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-24936000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	13073000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Tax OtherComprehensiveIncomeLossBeforeReclassificationsTax	0	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	13073000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	533000	usd
	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	0	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	533000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12540000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	2500000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	2600000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	90081	shares
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.242
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.026
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.776
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.430
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.30
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.30
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	16333000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1155000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25610000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8525000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54238000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53803000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54202000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53713000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	353000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	174000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	229000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54591000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53977000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54202000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53942000	shares
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q2	livn	Number Of Geographic Regions In Which Entity Operates NumberOfGeographicRegionsInWhichEntityOperates	3	geographic_region
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	318575000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	293882000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	613487000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	557300000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	40166000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	17376000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	56412000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	15034000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	15532000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14809000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	31425000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	28246000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-25482000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-3045000	usd
CY2023Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	2713000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-12116000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	28260000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	21589000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5280000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12611000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15048000	usd
CY2024Q2	us-gaap	Assets Assets	2453188000	usd
CY2023Q4	us-gaap	Assets Assets	2429563000	usd
CY2024Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	13751000	usd
CY2023Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	6055000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	20198000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	13906000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	782941000	usd
	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	-16573000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	766368000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	158055000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	154181000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	72467000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	81878000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16230000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12901000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	66025000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53108000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	154722000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	147887000	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	27000000.0	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24400000	usd
CY2024Q2	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	14968000	usd
CY2023Q4	livn	Medical Device Payback Current MedicalDevicePaybackCurrent	8223000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	14021000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	17794000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10225000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10725000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8843000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8362000	usd
CY2024Q2	livn	Interest Payable Current Net InterestPayableCurrentNet	7223000	usd
CY2023Q4	livn	Interest Payable Current Net InterestPayableCurrentNet	7840000	usd
CY2024Q2	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	6406000	usd
CY2023Q4	livn	Provision For Agents Returns And Other ProvisionForAgentsReturnsAndOther	4464000	usd
CY2024Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4531000	usd
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4441000	usd
CY2024Q2	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	3331000	usd
CY2023Q4	livn	Restructuring Related Liabilities RestructuringRelatedLiabilities	911000	usd
CY2024Q2	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	2489000	usd
CY2023Q4	livn	Research And Development Costs Payable Current ResearchAndDevelopmentCostsPayableCurrent	2462000	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	39000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3883000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	13750000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	25895000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	24446000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	97971000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	107301000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13400000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15300000	usd
CY2024Q2	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	5750000	usd
CY2023Q2	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	5750000	usd
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2183000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1230000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3105000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1008000	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	7337000	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	5528000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	14358000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	10064000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	104000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-185000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-265000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-407000	usd
CY2024Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-3045000	usd
CY2023Q2	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	2713000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	-12116000	usd
	livn	Foreign Currency Transaction Gain Loss And Other Nonoperating Income ForeignCurrencyTransactionGainLossAndOtherNonoperatingIncome	28260000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	329237000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	266504000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	303884000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	311368000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	633121000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	577872000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001639691-24-000109-index-headers.html	Edgar Link	pending
0001639691-24-000109-index.html	Edgar Link	pending
0001639691-24-000109.txt	Edgar Link	pending
0001639691-24-000109-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
livn-20240630.htm	Edgar Link	pending
livn-20240630.xsd	Edgar Link	pending
livn-20240630_g1.jpg	Edgar Link	pending
livn-2024630xex311.htm	Edgar Link	pending
livn-2024630xex312.htm	Edgar Link	pending
livn-2024630xex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
livn-20240630_cal.xml	Edgar Link	unprocessable
livn-20240630_def.xml	Edgar Link	unprocessable
livn-20240630_lab.xml	Edgar Link	unprocessable
livn-20240630_pre.xml	Edgar Link	unprocessable
livn-20240630_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIVN
LivaNova PLC Stock $livn

2024 Q3 Form 10-Q Financial Statement

#000163969124000109 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN LivaNova PLC Stock $livn

2024 Q3 Form 10-Q Financial Statement

#000163969124000109 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIVN
LivaNova PLC Stock $livn